These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25496344)

  • 21. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
    Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
    Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
    Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
    Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
    Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-based nanoparticles for highly efficient T1-weighted magnetic resonance imaging.
    Lim EK; Kang B; Choi Y; Jang E; Han S; Lee K; Suh JS; Haam S; Huh YM
    Nanotechnology; 2014 Jun; 25(24):245103. PubMed ID: 24872113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graphene oxide based theranostic platform for T1-weighted magnetic resonance imaging and drug delivery.
    Zhang M; Cao Y; Chong Y; Ma Y; Zhang H; Deng Z; Hu C; Zhang Z
    ACS Appl Mater Interfaces; 2013 Dec; 5(24):13325-32. PubMed ID: 24313343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadolinium toxicity: epidermis thickness measurement by magnetic resonance imaging at 500 MHz.
    Sharma R
    Skin Res Technol; 2010 Aug; 16(3):339-53. PubMed ID: 20637004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-related variable responses of calcium sensitive MRI probes.
    Mamedov I; Logothetis NK; Angelovski G
    Org Biomol Chem; 2011 Aug; 9(16):5816-24. PubMed ID: 21727986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Block copolymer-based gadolinium nanoparticles as MRI contrast agents with high T1 relaxivity.
    Hou S; Tong S; Zhou J; Bao G
    Nanomedicine (Lond); 2012 Feb; 7(2):211-8. PubMed ID: 22339134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchtop-MRI for in vivo imaging using a macromolecular contrast agent based on hydroxyethyl starch (HES).
    Besheer A; Caysa H; Metz H; Mueller T; Kressler J; Mäder K
    Int J Pharm; 2011 Sep; 417(1-2):196-203. PubMed ID: 21056646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
    Mohs AM; Lu ZR
    Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications.
    Wen S; Li K; Cai H; Chen Q; Shen M; Huang Y; Peng C; Hou W; Zhu M; Zhang G; Shi X
    Biomaterials; 2013 Feb; 34(5):1570-80. PubMed ID: 23199745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method for the making and utility of gadolinium-labeled albumin microbubbles.
    Anderson DR; Duryee MJ; Garvin RP; Boska MD; Thiele GM; Klassen LW
    Magn Reson Imaging; 2012 Jan; 30(1):96-103. PubMed ID: 22056512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers.
    Xue S; Qiao J; Jiang J; Hubbard K; White N; Wei L; Li S; Liu ZR; Yang JJ
    Med Res Rev; 2014 Sep; 34(5):1070-99. PubMed ID: 24615853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gd(3+)-Based Magnetic Resonance Imaging Contrast Agent Responsive to Zn(2+).
    Regueiro-Figueroa M; Gündüz S; Patinec V; Logothetis NK; Esteban-Gómez D; Tripier R; Angelovski G; Platas-Iglesias C
    Inorg Chem; 2015 Nov; 54(21):10342-50. PubMed ID: 26468992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
    Caravan P; Astashkin AV; Raitsimring AM
    Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.